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Sphingosine-1-phosphate, a key mediator in
immune cell trafficking, is elevated in the lungs
of asthmatic patients and regulates pulmonary
epithelium permeability. Stimulation of mast
cells by allergens induces two mammalian
sphingosine kinases (Sphk1 and Sphk2) to pro-
duce sphingosine-1-phosphate (S1P). Little is
known about the individual role of these kinases
in regulating immune cell function. Here we
show that in mast cells, Sphk2 is required for
production of S1P, for calcium influx, for acti-
vation of protein kinase C, and for cytokine
production and degranulation. However, sus-
ceptibility to in vivo anaphylaxis is determined
both by S1P within the mast cell compartment
and by circulating S1P generated by Sphk1
predominantly from a non-mast cell source(s).
Thus, sphingosine kinases are determinants
of mast cell responsiveness, demonstrating
a previously unrecognized relationship with
anaphylaxis.
INTRODUCTION
Sphingolipids are necessary constituents of membranes
found to concentrate in liquid ordereddomains (commonly
referred to as lipid rafts or cholesterol-enrichedmembrane
microdomains). Multiple cell-membrane receptors control
the activity of sphingosine kinases (SphKs), which gener-
ate the lysosphingolipid sphingosine-1-phosphate (S1P)
and modulate the amounts of the sphingosine (SPH) and
ceramide (Spiegel and Milstien, 2003). These sphingolipid
metabolites are bioactive lipids that can directly bind
proteins, activate signaling pathways, and affect cellular
responses (Hannun et al., 2001; Olivera and Spiegel,
2001).
S1P is an intracellular mediator of cell function and is
also an extracellular ligand for a family of five G protein-
coupled receptors, named S1P receptors (S1P1-5)(Sanchez and Hla, 2004). Recent studies that used the
immunosuppressive drug FTY720, a structural analog of
SPH that is phosphorylated in vivo by SphK creating
a S1P mimetic, revealed an essential role for S1P and its
receptors in lymphocyte trafficking (Rosen and Goetzl,
2005). Exit of thymocytes from the thymus is controlled
by upregulation in S1P1 expression during the maturation
of thymocytes, which mediates the chemotactic response
to S1P (Matloubian et al., 2004; Schwab et al., 2005).
Drugs interfering with the function of the S1P-S1P recep-
tor axis show promise in transplantation and in clinical
trials involving patients with relapsing multiple sclerosis
(Massberg and von Andrian, 2006). Furthermore, alter-
ation of the S1P gradient by dietary components impacts
on lymphocyte egress and immunity (Schwab et al., 2005),
highlighting the importance of preserving in vivo S1P
homeostasis. In certain inflammatory conditions such as
asthma and rheumathoid arthritis, local increases in the
amounts of S1P in the airways (Ammit et al., 2001) and
in the arthritic joints (Kitano et al., 2006), respectively,
have been reported. S1P receptors are ubiquitously ex-
pressed in a variety of cell types, and S1P dramatically
alters the function of endothelial, epithelial, and smooth
muscle cells (Ammit et al., 2001; Gon et al., 2005; Olivera
and Spiegel, 2001; Spiegel and Milstien, 2003), so S1P
may participate in the pathophysiology of these inflamma-
tory diseases.
Mast cells are potent producers of intracellular and se-
creted S1P via SphK activation. Mast cells express S1P1
and S1P2 receptors on their cell surface (Olivera and
Rivera, 2005). Similar to T cells, S1P1 is important for
mast cell chemotaxis. In contrast, S1P2 contributes to the
robustness of the mast cell degranulation response (Jolly
et al., 2004). S1P has also been suggested as an important
regulator of calcium mobilization in mast cells, through an
unknown mechanism that is seemingly independent of
S1P receptors (Choi et al., 1996; Lee et al., 2005a; Melen-
dez and Khaw, 2002). The balance of SPH to S1P has also
been implicated as a rheostat that controls the mast cells
responsiveness to a stimulus (Prieschl et al., 1999). This
view predicts that SphK activation is a key checkpoint in
mast cell function and that it should be closely linked to
cell-surface receptor stimulation. This was demonstratedImmunity 26, 287–297, March 2007 ª2007 Elsevier Inc. 287
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Sphingosine Kinases and Anaphylaxisto be the case for the high-affinity receptor for IgE (Fc3RI):
we previously found that activation of both SphK1 and 2
was dependent on Fc3RI-mediated activation of Fyn and
Lyn (Olivera et al., 2006; Urtz et al., 2004), the Src family
kinases that are promptly activated upon receptor en-
gagement (Rivera and Gilfillan, 2006). However, the pre-
cise role of each SphK isoform in mast cells has not
been conclusively demonstrated. Furthermore, because
S1P is present in plasma in relatively high amounts and ex-
tracellular S1P in vitro can influencemast cell responses, it
was important to understand whether the contributions of
these kinases to mast cell function can be compensated
in vivo by S1P in the surrounding environment.
By usingmice in which SphK1 and 2 geneswere individ-
ually or jointly deleted, we investigated their role in mast
cell function. Several unanticipated findings resulted
from this analysis. SphK2, and not SphK1, was found to
be the main regulator of S1P production, mediating cal-
cium influx, NF-kB activation, cytokine production, and
degranulation of mast cells. In contrast, SphK1 deficiency
did not markedly alter mast cell signals or function; how-
ever, mice deficient in this gene had greatly reduced
amounts of circulating S1P. In vivo anaphylaxis revealed
that circulating amounts of S1P were important in deter-
mining mast cell responsiveness and demonstrated a
partnership between SphK1 and SphK2 as extrinsic and
intrinsic regulators, respectively, of mast cell responsive-
ness. This previously unrecognized in vivo role for SphK-
generated S1P may be a key determinant of anaphylaxis.
RESULTS
Characterization of SphK-Deficient Mast Cells
To assess the role of the individual sphingosine kinases
(SphK1 and SphK2) in mast cells, we utilized genetically
altered mice in which the individual genes were deleted
or both genes (Sphk1 and Sphk2) were jointly deleted.
The deletion of both genes results in embryonic lethality
(Mizugishi et al., 2005), so we harvested mast cell progen-
itors from the liver of 11.5-day-old embryos for each
genotype and differentiated these cells in culture with
IL-3 and stem cell factor (SCF) (Kovarova et al., 2006; Sai-
toh et al., 2000). Alternatively, in vivo studies on Sphk1/
and Sphk2/ mice as well as in vitro analysis of bone
marrow-derived mast cells (BMMCs) from these mice
were also conducted (see following sections). The differ-
entiated cells from each genotype showed equivalent
cell-surface Fc3RI expression and absence of mRNA for
the corresponding targeted gene (Figures 1A and 1B).
By using an assay that distinguishes the activity of the
two kinases (Liu et al., 2000; Olivera et al., 2006), we found
the appropriate kinase activity to be reduced (Figure 1C).
As previously described (Olivera et al., 2006), some over-
lap (25%) of SphK activity was seen in this assay. This
overlap in activity likely explains the higher-than-expected
SphK1 activity observed in Sphk1/ mast cells, because
SphK2 activity was approximately 2-fold greater. Mea-
surement of sphingosine (SPH) and sphingosine-1-phos-
phate (S1P) amounts indicated that the absence of288 Immunity 26, 287–297, March 2007 ª2007 Elsevier Inc.SphK2, but not SphK1, resulted in increased amounts of
SPH and decreased S1P production, demonstrating that
this was the dominant kinase producing S1P in these cells
(Figures 1D and 1E).
Impaired Mast Cell Effector Functions
in SphK2-Deficient Cells
The role of SphK1 or 2 on mast cell responses was
explored. The loss of SphK2, but not SphK1, caused
a marked inhibition (>60%) in the Fc3RI-dependent
degranulation (Figure 2A). This inhibition in Sphk2/ cells
could be partly restored by concomitant addition of S1P
as a stimulus (see Figure S1 in the Supplemental Data
available online). Deficiency of both SphKs did not aug-
ment this inhibition (Figure 2A). Measurement of TNF,
IL-6, and IL-13 secretion also revealed a dependence on
SphK2 (Figures2B–2D). Importantly, normal cytokine secre-
tion was restored when Sphk2/ or Sphk1/Sphk2/
mast cells were treated with the generic stimulus of
phorbol 12-myristate 13-acetate (PMA) and the calcium
ionophore A23187. As shown in Figures 2E and 2F, both
arachidonic acid (AA) release and leukotriene B4 (LTB4)
production were impaired in Sphk2/ mast cells. These
findings demonstrate a role for SphK2 downstream of
Fc3RI and distinguish the role of this kinase from that of
SphK1 in regulating mast cell effector responses.
SphK2-Deficient Mast Cells Have Defective
Calcium Influx
The impaired degranulation, cytokine secretion, and
arachidonic acid release suggested that SphK2 activity
might impact on a signaling element in common to these
three responses. SphK1 and S1P have been implicated
in mast cell calcium mobilization from intracellular stores
(Choi et al., 1996; Melendez and Khaw, 2002). Consider-
able evidence argues for a dominant role of inositol
(3,4,5)-trisphosphate (IP3), rather than S1P, in mobilizing
calcium in mast cells, as well as other immune cells
(Michell et al., 1992). Conversely, other studies suggested
that the Fc3RI principally utilized SphK tomobilize calcium
(Choi et al., 1996; Melendez and Khaw, 2002).
Analysis of the Fc3RI-dependent calcium response re-
vealed an impairment in the extent of the response in
the absence of SphK2, but not SphK1 (Figure 3A). Cells
in which both kinases were absent showed no further
reduction, demonstrating a dominant role for SphK2 in
regulating calcium. This was further supported by exper-
iments in which WT or Sphk1/Sphk2/mast cells were
treated with N,N-Dimethylsphingosine (DMS), a competi-
tive inhibitor of SphK activity (Edsall et al., 1998; Liu et al.,
2000). DMS similarly reduced the calcium response in WT
cells, but had minor effects in Sphk1/Sphk2/ mast
cells (Figure S2). We explored whether the SphK2 effect
was through IP3 production, which causes calcium re-
lease from endoplasmic reticular stores. SphK deficiency,
in general, had no significant effect on mast cell IP3 pro-
duction (Figure 3B). Tyrosine phosphorylation of PLCg1
and PLCg2, the enzymes that produce IP3 in mast cells
(Saitoh et al., 2003), was normal, though some minimal
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sine Kinase-Deficient Fetal Liver-
Derived Mast Cells
(A) Cell-surface expression of Fc3RI in
Sphk1/, Sphk2/, and Sphk1/Sphk2/
mast cells as compared toWTmast cells. Cells
were incubated with FITC-labeled IgE and
fluorescence intensity was measured by flow
cytometry. The red line represents the isotype
control that used FITC-rat IgG1 instead of
FITC-IgE. The numbers indicate the mean
fluorescence intensity of each sample.
(B) RT-PCR analysis of expression of SphKs
mRNA.
(C) SphK1 or 2 activities from cells were
determined by means of assay conditions
that favor SphK1 (in the presence of Triton-
micelles) or SphK2 (in the presence of higher
salt concentrations) as described in Experi-
mental Procedures.
(D and E) Cellular S1P (D) and SPH (E) were
measured as described (Olivera et al., 2006).
Data represent the mean ± SEM of 3 to 4 inde-
pendent experiments. Statistical significance
relative toWT cells was **p < 0.01; ***p < 0.001.loss of phosphorylation was observed for PLCg2 when
both SphKs were absent (Figure S2).
Because IP3 production appeared to be normal, we
explored whether the loss of SphK2 was impinging on
intracellular calcium mobilization independently of IP3.
By removing calcium from the extracellular medium, the
Fc3RI-dependent release of Ca2+ from intracellular stores
can be measured and was found to be normal among the
different genotypes (Figure 3C). In contrast, replenishment
of Ca2+ in the medium, after 10 min of Fc3RI stimulation in
the absence of Ca2+, revealed a defect in its uptake for
Sphk2/ and Sphk1/Sphk2/ mast cells, but not for
Sphk1/ cells. This defect in calcium influx was further
confirmed by direct measurement of 45Ca2+ uptake, which
demonstrated a marked (>60%) inhibition for Sphk2/
and Sphk1/Sphk2/ mast cells (Figure 3D). However,
an artificial increase of intracellular calcium by ionophore
A23187, in combination with PMA,was able to fully restore
degranulation in Sphk2/ and Sphk1/Sphk2/ mast
cells (Figure 3E), demonstrating that defective degranula-
tion could be restored by increasing the intracellular
calcium concentration and activating PKC.SphK2-Deficient Mast Cells Show Defective PKC
Translocation and NF-kB Activation
Calcium is necessary for the activation of the calcium-
binding isoforms of PKC, of which the membrane translo-
cation and function of PKCb has been demonstrated as
important for mast cell degranulation and IL-6 production
(Nechushtan et al., 2000; Ozawa et al., 1993). Thus, we
explored whether loss of SphK2 affected the translocation
of phosphorylated PKCs inmast cells. The translocation of
membrane-localized S660-phosphorylated PKCs a and
b (which reflects mature and active PKC [Behn-Krappa
and Newton, 1999]) was impaired in Sphk2/ and
Sphk1/Sphk2/ mast cells. Membrane translocation
and phosphorylation of these PKC isoforms was not de-
fective in Sphk1/mast cells. These results demonstrate
that SphK2 is essential for normal targeting of active PKCa
and b to mast cell membranes where they may exert their
exocytotic function (Ozawa et al., 1993).
Because cytokine production was impaired by SphK2
deficiency, and TNF and IL-6 production is NF-kB depen-
dent in mast cells (Marquardt and Walker, 2000), we ex-
plored the role of SphKs in NF-kB activation. We observedImmunity 26, 287–297, March 2007 ª2007 Elsevier Inc. 289
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DerivedMast Cells Have Defective Effec-
tor Responses
(A) Cells of the indicated genotype were stimu-
lated via Fc3RI, and degranulation was
measured by release of the granule enzyme
b-hexosaminidase. The fraction of enzyme
released in the medium after stimulation is ex-
pressed as a percent of total cellular content.
(B–D, F) Cytokine (B–D) or leukotriene (F) B4
release into the extracellular media was quan-
titatively measured by specific immunoasays.
(E) Mast cells were loaded with 14C-labeled
arachidonic acid (AA) before Fc3RI stimulation.
The released AA detected in the extracellular
medium is expressed as the percent of total
14C-labeled AA incorporated in the cell. Data
are the mean ± SEM of 3 to 5 independent ex-
periments. Statistical significance relative to
WT cells was *p < 0.05; **p < 0.01; ***p < 0.001.a marked defect (>60%) in nuclear NF-kB activity in
Sphk2/ and Sphk1/Sphk2/ mast cells, but not in
Sphk1/ mast cells (Figure 4B). Normal NF-kB activity
was restored when Sphk2/ and Sphk1/Sphk2/
cells were treated with PMA and calcium ionophore
A23182 (Figure 4C), demonstrating a calcium- and PKC-
mediated restoration. Assembly of the CARMA1-Bcl10-
Malt complex required for NF-kB activation in T and B
cells is dependent on PKCq and b, respectively (Lee
et al., 2005b; Wang et al., 2004). In mast cells, which
PKC isoform is responsible for NF-kB activation is un-
known (Klemm et al., 2006; Rivera, 2006a), although
PKCb is a likely candidate (Nechushtan et al., 2000).
The activation of MAP kinases, which are known to reg-
ulate cytokine expression, was also studied. These ki-
nases were normally activated (Figure 4D), demonstrating
that SphKs are not essential for their activity.
Regulation of Circulating S1P by SphK1 and Intrinsic
Mast Cell SphK2 Activity Determine
the Anaphylactic Response
To test the in vivo role of SphKs, we conducted a passive
systemic anaphylactic challenge of mice (Saitoh et al.,
2000). Challenge of WT mice resulted in histamine release
ranging from 10 to 30 mM, and analysis of the serum con-290 Immunity 26, 287–297, March 2007 ª2007 Elsevier Inc.centrations of S1P in these mice revealed a strong associ-
ation between the concentration of this sphingolipid and
the concentration of circulating histamine (Figures 5A
and 5B). In vivo challenge of Sphk1/ and Sphk2/
mice revealed a defect in the anaphylactic response in
Sphk1/ but not Sphk2/ mice (Figure 5B). The latter
mice had increased mast cell numbers, although mast
cells from these mice produced little S1P and were less
responsive (Figures 1D and 2 and Figures S3 and S4).
However, as previously reported (Mizugishi et al., 2005;
Zemann et al., 2006) and confirmed herein, Sphk2/
mice had abnormally high amounts of circulating S1P
relative to WT mice (>150%, Figure 5C). Given the associ-
ation of S1P with the concentrations of histamine shown
in Figure 5A, and the finding that S1P can influence
mast cell responsiveness in vitro (Figure S1; Jolly et al.,
2004; Prieschl et al., 1999), the results suggested an ex-
trinsic role of S1P, through SphK1, in regulating mast
cell responsiveness in vivo. Supporting this concept, the
anaphylaxis-resistant Sphk1/ mice had low concentra-
tions of circulating S1P relative to their WT counterparts
(Figure 5C; Allende et al., 2004; Zemann et al., 2006),
whereas degranulation of mast cells derived from these
mice was completely normal (Figure 2 and Figure S4).
To further test this hypothesis, we generated Sphk2/
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Sphingosine Kinases and AnaphylaxisFigure 3. SphK2 Deficiency in Fetal Liver-Derived Mast Cells Reduces Fc3RI-Dependent Ca2+ Influx but Not the Generation of IP3
and Intracellular Calcium Mobilization
(A) Mast cells with the indicated genotype loaded with the FURA-2AMwere stimulated via Fc3RI. FURA-2AM flouresence at 510 nmwasmeasured by
rapid excitation between 340 and 380 nm. Maximum and minimum emissions were used to calculate the intracellular calcium concentrations.
(B) IP3 production wasmeasured after Fc3RI stimulation. Intracellular IP3 was extracted and quantified as described in Experimental Procedures. Data
are the mean ± SEM of 5 independent experiments (differences were not statistically significant).
(C) FURA-2AM-loaded mast cells were stimulated via Fc3RI in the absence of extracellular calcium and flouresence emission was monitored. 10 min
after stimulation, 1 mM calcium was added to the medium.
(D) Fc3RI-dependent calcium influx was measured by adding 45Ca2+ to the medium at the time of stimulation. After 10 min, intracellular 45Ca2+ was
determined by scintillation counting and expressed as percent of the total 45Ca2+ added.
(E) PMA and calcium ionophore A23187 treatment restores the defective degranulation response. Mast cells were stimulated with these agents for
10 min and b-hexosaminidase release to the extracellular medium was determined. Data shown (B, D, E) are mean ± SD of at least three independent
experiments. Statistical significance with respect to WT cells was *p < 0.05; **p < 0.01; ***p < 0.001.mice with one active SphK1 (Sphk1+/) allele (Sphk1+/
Sphk2/) and Sphk1/ mice with one active SphK2
(Sphk2+/) allele (Sphk1/Sphk2+/). Sphk1+/Sphk2/
mice, unlike their Sphk2/ counterparts, had normal
amounts of circulating S1P (Figure 5C), and their mast
cells had similarly low SphK activity as those derived from
the Sphk2/mice (Figure S5). However, these mice were
now resistant to anaphylaxis (Figure 5B), despite having
higher numbers of mast cells (like the Sphk2/ mice) in
their tissues (Figure S3). Sphk1/Sphk2+/ mice had
low amounts of circulating S1P similar to Sphk1/ mice
but had mast cells with diminished SphK activity com-
pared to thosederived from theSphk1/mice (FigureS5).
Sphk1/Sphk2+/ mice were more resistant to anaphy-
laxis than Sphk1/ mice (Figures 5B and 5C). Measure-
ment of the SphK activity in the blood for all genotypes
demonstrated SphK1 dominance in the circulatory
system. As expected, the corresponding reduction of
SphK1 activity was observed when this gene was not ex-
pressed or when a single allele was active (Figure S5).
Moreover, the presence or absence of mast cells in an un-
challenged mast cell-deficient mouse (Wsh/Wsh) did notalter the amounts of circulating S1P (Figure S6). The in vivo
experiments support the view that both SphK1 and 2 play
essential roles as extrinsic and intrinsic regulators,
respectively, of allergic responses.
DISCUSSION
The findings of this study reveal a key role for SphKs and
S1P in mast cell responses and anaphylaxis. Although
multiple studies suggested that sphingolipid metabolites
might contribute in mast cell activation, direct evidence
of a role for such metabolites in mast cell signaling and
in vivo function was lacking. Clues for a role in mast cell
effector functions were provided by studies reporting
increased S1P amounts in the bronchial alveolar lavage
of challenged asthmatics (Ammit et al., 2001) and in vitro
experiments demonstrating that S1P is required for sus-
tained mast cell degranulation through the S1P2 receptor
(Jolly et al., 2004). Thus, understanding the individual roles
of SphK1 and SphK2 inmast cell responsiveness and their
importance for mast cell function in vivo was necessary.Immunity 26, 287–297, March 2007 ª2007 Elsevier Inc. 291
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Sphingosine Kinases and AnaphylaxisFigure 4. SphK2 Deficiency in Fetal Liver-Derived Mast Cells Results in Defective PKC and NF-kB Activation
(A) Fc3RI-stimulated cells were lysed by freeze-thawing and total membranes were isolated. Membrane-translocated PKC (a and b isoforms) and
total PKC phosphorylated on S660 was detected by immunoblot with an antibody that recognizes both isoforms and a phospho-pan PKC antibody,
respectively. Immunoprobe of the same lysate for actin showed equal protein loading.
(B) Nuclear NF-kB p65 DNA binding activity was measured 20 min after Fc3RI stimulation.
(C) Nuclear NF-kB p65 DNA binding activity was also measured from PMA and calcium ionophore A23187-treated cells. Activity is reported as the
absorbance at 450 nm. Data are the mean ± SEM from 3 to 5 individual experiments. Statistical significance with respect to WT cells was **p < 0.01.
(D) SphK deficiency does not affect MAPK or PI3K-AKT pathways. Phosphorylated proteins in the lysates of Fc3RI-stimulated cells were analyzed by
immunoblotting with phospho-specific ERK1/2 (Thr202 Tyr204), p38 (Thr180 Tyr182), JNK1/2 (Thr183 Tyr185), and Akt (Ser473), and the respective
antibodies recognizing total protein.This analysis has provided several original and unfore-
seen findings. SphK2 was found to be an intrinsic regula-
tor of mast cell calcium influx and responses, whereas
SphK1 appears to be important in regulating the levels
of circulating S1P and thus extrinsically affecting mast
cell responsiveness. This is conflicting with the previous
suggestions that SphK1 is the key isoform in mast cells
(in experiments that used pharmacological inhibitors or
siRNA silencing strategies), because its activity has been
implicated in calcium responses in the RBL-2H3 mast
cell line and in human mast cells (Lee et al., 2005a; Melen-
dez and Khaw, 2002). However, our view is supported by
several lines of evidence. (1) Direct measurement of
SphK1 and 2 activity in fetal liver-derived mast cells as
well as in bone marrow-derived cultured mast cells
(BMMC) demonstrated the higher activity of the latter iso-
form. (2) Both fetal liver-derived mast cells and BMMC
from Sphk2/mice demonstrated defective S1P produc-
tion and Fc3RI-induced degranulation, unlike those of
Sphk1/ mice. (3) Fetal liver-derived mast cells from292 Immunity 26, 287–297, March 2007 ª2007 Elsevier Inc.Sphk1/Sphk2/ mice mirrored Sphk2/ cells, but
not Sphk1/ cells, in both signaling and functional re-
sponses. (4) Sphk1+/Sphk2/ mice had normal levels
of circulating S1P, unlike the Sphk2/ mice, but were
resistant to anaphylaxis (in vivomast cell response). Taken
together with the finding of increasedmast cell numbers in
both Sphk2/ as well as in Sphk1+/ Sphk2/mice, and
of approximately equal SphK1 activity in mast cells from
these mice, one is led to conclude that the likely determi-
nant for the normal anaphylactic response of theSphk2/
mouse is the high levels of circulating S1P. This view is
also supported by the partial restoration of degranulation
for Sphk2/ mast cells when concomitantly stimulated
with Ag and S1P. On the other hand, this short-term treat-
ment with exogenous S1P alone (or in combination with
Ag) failed to restore the normal rise in intracellular calcium
and the defective calcium influx observed in Sphk2/
cells, demonstrating that SphK2 has a role in mast cell
functions that are independent of S1P receptors. Alto-
gether, the data implicate SphK2 as a determinant of
Immunity
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trinsic role. Nonetheless, given the diversity and plasticity
of mast cells (Galli et al., 2005) in the in vivo environment
and the important differences in the gene expression pro-
files of human and mouse mast cells (Welle, 1997; Saito,
2005), we cannot formally exclude an intrinsic role for
Figure 5. The In Vivo Passive Systemic Anaphylactic Re-
sponse Is Associated with Circulating S1P Concentrations
and Mast Cell SphK2
(A) Correlation between S1P concentrations in serum and plasma his-
tamine concentrations in WT mice after the anaphylactic response.
Linear correlation coefficient is shown.
(B) WT, Sphk1/, Sphk2/, and mice deficient for SphK2 and hemi-
zygous for SphK1genes (Sphk1+/ Sphk2/) or vice versa (Sphk1/
Sphk2+/) were passively sensitized with DNP-specific IgE and chal-
lenged 24 hr later with Ag (DNP-HSA) or pseudochallenged with an
equal volume of saline. Plasma histamine concentration was mea-
sured by competitive ELISA. Statistical significance relative to WT is
*p < 0.04, ***p < 0.001.
(C) S1P in the serum of unchallenged WT, Sphk1/, Sphk2/,
Sphk1/ Sphk2+/, and Sphk1+/ Sphk2/ mice was measured as
in a previously described enzymatic assay (Edsall et al., 2000). Statis-
tical significance relative to WT mice was ***p < 0.001.SphK1 in mast cells phenotypically different from those
used in this study.
Our previous findings (Olivera et al., 2006; Urtz et al.,
2004) demonstrated a Fc3RI-proximal activation and
association of SphKs suggestive of their key role in deter-
mining mast cell functional responses. The Src family
kinases, Lyn and Fyn, were found to be required for normal
activation of SphK activity in mast cells (Olivera et al.,
2006; Urtz et al., 2004). Lyn was important for the early
onset of SphK1 activity, whereas Fyn was obligatory for
the activation of both SphK1 and 2. Interestingly, fyn/
mast cells have a similar phenotype to Sphk2/ mast
cells. Both are defective in degranulation and cytokine re-
sponses and are unable to activate NF-kB (Gomez et al.,
2005; Parravicini et al., 2002; and this study). Ag-stimu-
lated fyn/ mast cells also have markedly decreased
S1P amounts relative to WT cells (Olivera et al., 2006),
whereas lyn/ mast cells achieve normal S1P levels,
though the onset is delayed (unpublished observation).
Because Sphk2/ mast cells showed defective calcium
influx, we recently revisited this issue in fyn/ BMMCs.
These new findings demonstrate that Fyn deficiency
also results in decreased calcium influx (J.R., data not
shown). Thus, SphK2 is a candidate kinase for regulation
of calcium influx downstream of Fyn.
While the detailed mechanism by which SphK2 regu-
lates calcium mobilization remains to be fully explored, it
should be noted that unlike a previous suggestion (Lee
et al., 2005a), we uncovered no evidence of a role for
SphKs or S1P in mobilizing calcium from ER stores. Intra-
cellular S1P formation has been reported to promote cal-
cium-induced calcium entry in human neutrophils (Itagaki
and Hauser, 2003) and calcium influx in yeast (Birchwood
et al., 2001). In contrast, SPH has been described to inhibit
calcium influx (Blom et al., 2005; Condrescu et al., 2002;
Mathes et al., 1998; Titievsky et al., 1998). Of particular in-
terest, the study by Mathes et al. (1998) in the tumor mast
cell line RBL-2H3 implicates SPH (and its structural ana-
logs) as specific inhibitors of store-operated calcium re-
lease-activated calcium current (iCRAC). Thus, a possible
mechanism by which SphK2 might exert its activating ef-
fect on calcium influx could be through reducing the levels
of SPH via S1P generation, thereby derepressing the
block of iCRAC. This view fits well with a SPH:S1P rheo-
stat mechanism in mast cell responsiveness as proposed
by Prieschl and colleages (Prieschl et al., 1999). In these
experiments, high concentrations of intracellular SPH pre-
vented leukotriene synthesis and cytokine production and
inhibited MAP kinase activation. It should be noted that
SPH and lysosphingolipids are also potent inhibitors of
PKC activation as well, as shown by the fact that they
bind to the regulatory domain preventing interactions
of PKC with its stimulatory ligand, diacyglycerol (DAG)
(Hannun and Bell, 1989). Thus, upon Fc3RI stimulation
and activation of SphK2, a decrease in intracellular SPH
levels may derepress iCRAC and at the same time cause
increased activation of PKCs, like the b isoform, which is
essential for mast cell cytokine production and degranula-
tion (Nechushtan et al., 2000; Ozawa et al., 1993).Immunity 26, 287–297, March 2007 ª2007 Elsevier Inc. 293
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sociation between circulating concentrations of S1P and
anaphylaxis is most intriguing. These data argue that the
concentrations of circulating S1P in mice is primarily de-
termined by SphK1 outside the mast cell compartment
and demonstrate that deficiency in this kinase, which
results in reduced circulating S1P, is associated with
resistance to anaphylaxis even though the mast cells
from Sphk1/ mice contain normal intracellular amount
of S1P and were unaffected in their responses. Although
mast cells can release large amounts of S1P under sti-
mulation, when unchallenged mast cell-deficient mice
(Wsh/Wsh) were reconstituted with mast cells, the circu-
lating amounts of S1P were unchanged, demonstrating
that cells other than mast cells are likely to be the major
contributors to the resting amounts of S1P. The cellular
source of circulating S1P has not been clearly determined,
but endothelial cells, which secrete SphK1, and platelets
or other blood cell types could be likely sources (Venka-
taraman et al., 2006; Yatomi et al., 1995).
The recent work of Metz et al. (2006) demonstrated that
mast cell degranulation elicited by a systemic challenge
can be protective in mice. In this study, WT mice and
mast cell-deficient mice (W/Wv orWsh/Wsh) were sys-
temically challenged with snake or bee venom, but only
the mast cell-deficient mice were found to succumb to
this challenge. The release of the granule protease car-
boxypeptidase A (CPA) was key to the protective effect,
because a neutralizing antibody or silencing (shRNA) of
CPA expression caused increased mortality in WT mice.
This suggests that mast cell degranulation is likely to be
protective rather than detrimental even under conditions
of systemic challenge (Rivera, 2006b). This presents a
conundrum of why only few allergic individuals, when
systemically challenged with an allergen, undergo ana-
phylactic shock, while most others with similar circulating
levels of allergen-specific IgE are resistant (Pumphrey,
2004). The findings of the present study suggest the pos-
sibility that the circulating amounts of S1Pmay be a factor
that elicits an overly extensive degranulation of mast cells
that is thought to cause the anaphylactic response.
Importantly, this work further demonstrates that the in vivo
environment in which the mast cell resides is a key
determinant of its responsiveness and of susceptibility
to anaphylaxis. These findings have important clinical
and therapeutic implications in allergic disease, particu-
larly because SphK-specific inhibitors are under develop-
ment (Kim et al., 2005).
EXPERIMENTAL PROCEDURES
Mice, Liver-Derived Mast Cell Isolation, and Differentiation
Mice were maintained and used in accordance with National Institutes
of Health (NIH) guidelines and an animal study proposal approved by
the institutional animal care and use committee. The embryos of
genetically altered mice (129Sv 3 C57BL6 mixed background) were
obtained at 11.5 days of pregnancy. WT and Sphk1/ embryos
littermates were obtained by mating Sphk1+/ mice, whereas
Sphk2/ and Sphk1/Sphk2/ littermates were obtained by mating
Sphk1+//Sphk2/ mice. Genotyping was performed as described294 Immunity 26, 287–297, March 2007 ª2007 Elsevier Inc.(Allende et al., 2004; Mizugishi et al., 2005). Cell progenitors from the
embryonic livers were isolated and cultured as described (Kovarova
et al., 2006).
Immunoblots and Immunoprecipitations
For immunoprecipitations and immunoblotting procedures, cells
(30 3 106 and 10 3 106, respectively) were sensitized with 0.05 mg
IgE per million cells for 3 hr in Tyrodes-0.05% fatty acid-free BSA
buffer (Olivera et al., 2006), washed, and challenged with 100 ng/ml
of Ag (DNP36-BSA). Cells were solubilized as described (Parravicini
et al., 2002). Protein concentrations were determined to ensure equal
loading. For immunoblots of cell membrane proteins, cells were lysed
by freeze-thawing followed by centrifugation at 800 3 g for 10 min to
remove nuclei and cell debris. The clarified lysates were then centri-
fuged at 100,000 3 g for 1 hr. Recovered membranes were washed
with PBS and solubilized in SDS-PAGE sample buffer.
b-Hexosaminidase, Cytokine, LTB4, and Arachidonic Acid
Release Assays
The enzymatic activity of the granule marker, b-hexosaminidase, re-
leased to the extracellular media was measured as described (Saitoh
et al., 2000) from the supernatants of cells challenged with indicated
concentrations of Ag for 10 min.
For cytokine measurements, cells were sensitized overnight (5 to
10 3 106 per sample) with 0.01 mg IgE per million cells and stimulated
with the indicated concentration of Ag or alternatively with PMA
(40 nM) and calcium ionophore (A23187, 800 nM) in serum-, SCF-,
and IL-3-free medium containing 0.05% fatty acid-free BSA and
EDTA-free Protease Inhibitor Cocktail Tablet (Roche Diagnostics) for
4 hr at 37C in a CO2 incubator. For LT measurements, IgE-sensitized
cells (2.0 3 106 per sample) were pretreated for 30 min with 10 mg/ml
indomethacin and stimulated with the indicated concentrations of Ag
in Tyrode’s-BSA for an additional 30 min at 37C. Cells were then
centrifuged and the supernatants collected. TNF, IL-6, IL-13, or LTB4
were measured by specific ELISA. For arachidonic acid release,
mast cells (106 per sample) were loaded with 0.1 mCi 14C-labeled
arachidonic acid and sensitized with IgE overnight at 37C. Cells
were washed with Tyrode’s-BSA and activated with 25 ng/ml Ag for
the indicated time, and the percent arachidonic acid released in the
medium was determined from total cellular content as described
(Gomez et al., 2005).
Passive Systemic Anaphylaxis
Mice were sensitized with 3 mg of DNP-specific IgE by retro-orbital in-
jection. 24 hr later, mice were challenged with 300 mg of Ag (DNP36-
HSA) or vehicle (PBS) by retro-orbital injection. After 1.5 min, mice
were euthanized with CO2, and blood was immediately withdrawn by
cardiac puncture. Plasma histamine concentration was determined
with a competitive histamine immunoassay kit (Beckman Coulter).
Nuclear NF-kB DNA-Binding Assay
Cells (93 106 cells per sample) were sensitized with 0.05 mg of IgE for
3 hr at 37C and activated for 20 min with 30 ng/ml Ag or with 40 nM
PMA plus 800 nM Ionophore. Nuclear proteins were obtained with
a commercial kit (Active Motif), and nuclear NF-kB DNA binding activ-
ity was determined as described (Gomez et al., 2005).
Intracellular Calcium Determinations, Calcium Uptake,
and IP3 Measurements
For intracellular calcium measurements, cells were sensitized over-
night and loaded with 3 mM FURA-2AM for 20 min, washed, and
aliquoted in 96-well plates (9 3 104 cells/well). After 20 min, cells
were challenged with Ag (25 to 50 ng/ml), and changes in intracellular
calcium were monitored with a microplate fluorescence reader (Opti-
Fluor; BMG Labtechnologies). FURA-2 emission at 510 nm during
fast excitation between 340 and 380 nm at 37C was measured, and
background fluorescencewasdeterminedby addingMn2+, a quencher
of Fura-2 fluorescence, to a final concentration of 5 mM. The ratio of
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background values was calculated for each measurement. The ratio of
maximal (Rmax) and minimal (Rmin) intracellular concentrations was
determined in cells treated with 1% Triton X-100 (max) or 0.5 mM
EGTA (min). Intracellular calcium concentrations were calculated
from the equation: Free [Ca2+] = Kd[(R  Rmin/Rmax  R)(380lmin/
380lmax)], where Kd = 224. For calcium uptake, sensitized cells (2 3
106/sample) were stimulated in Tyrodes/BSA for 15 min in the pres-
ence of 5 mCi 45Ca2+. After washing, incorporated 45Ca2+ was mea-
sured by scintillation counting. Intracellular IP3 was extracted with
20% cold perchloric acid from IgE-sensitized cells (10 3 106/sample)
challenged with 25 ng/ml Ag. The acidified samples were centrifuged
at 2000 3 g for 15 min at 4C, and the supernatants were neutralized
with a 1:1 (v/v) mixture of 1,1, 2-trichlorotrifluoroethane:tri-n-
octylamine. The concentration of IP3 in each sample was measured
with a competitive binding assay (IP3-[
3H] Biotrak Assay System,
Amersham Biosciences).
RNA Extraction, RT-PCR, and Taqman
Total RNAwas isolated from 2 to 43 106 cells with a double extraction
with Trizol (Invitrogen) according to manufacturer’s instructions and
further purified with a RNA purification kit (RNeasy, Quiagen). For
Sphk2 alleles, RNA was reverse transcribed with the SuperScript
First-Strand Synthesis System for reverse transcription (RT)-PCR
(Invitrogen), as specified by the manufacturer, and PCR was per-
formed with primers P1 (50-ACCACTTATGAGGAGAATCG-30) and P2
(50-CACCACGTGGTCCATACAGC-30). Each PCR cycle consisted of
30 s of denaturation at 94C, 30 s of annealing at 55C, and 2 min of
extension at 72C. For Sphk1 alleles, purified RNA was reversed
transcribed and amplified by PCR in one step (PowerScriptTM One-
Step qRT-PCR Mix, Clontech Laboratories, Inc.) with the primers P3
(50-TGTCACCCATGAACCTGCTGTCCCTGCACA) and P4 (50-TGAGA
AGGCACTGGCTCCTCCAGAGGAACAAG) and exactly according to
the thermal cycle conditions specified by the manufacturer. Glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) was used to monitor
RNA recovery in each of the reactions.
Sphingosine Kinase Activity and Mass Measurement
of S1P and SPH
SphK1 and 2 activities were independently and differentially measured
with a 20%–30% overlap exactly as described (Olivera et al., 2006).
SPH and S1P recovered from cell extracts or S1P recovered from se-
rum samples were quantified by an enzymatic assay with cell lysates
from HEK293 cells overexpressing SphK1 exactly as described
(Olivera et al., 2006).
Determination of Mast Cell Numbers
5 ml of RPMI media containing 10% serum was injected in the perito-
neum of euthanized mice, and the peritoneal lavage was recovered
after the abdomen was lightly massaged. Peritoneal cells were centri-
fuged and stained in 1% BSA-PBS with antibodies to c-KIT (Allophy-
cocyanin-conjugated [APC]) and a combination of phycoerythrin-
conjugated anti-Fc3RI plus phycoerythrin-conjugated IgE or with the
appropriate IgG isotype control combinations and sorted by flow
cytometry with a FACScan (Becton Dickinson). Mast cells (which
showed double-positive staining for c-KIT and Fc3RI) were quantified
as the percent of the total cells in the peritoneal lavage. Samples of
dorsal skin and stomach from euthanized mice were fixed in 10% buff-
ered formalin and embedded in paraffin, and sections were stained
with toluidine blue at low pH and counterstained with eosine. Meta-
chromatic-stained mast cells were counted in each field (2 mm2)
with a microscope that used 163 objective.
Statistical Analysis
Statistical analysis was performed with PRISM GRAPHPAD Software.
For most comparisons, a nonpaired Student’s t test was used. For
comparing responses of the various mutant cells over time, a two-
way Anova test was used, as indicated.Supplemental Data
Six Supplemental Figures can be found with this article online at http://
www.immunity.com/cgi/content/full/26/3/287/DC1/.
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